Nervgen Pharma NGEN
NASDAQ NGEN
$1.35 +0.02 (+1.50%)
At close: Nov 11, 2026 · 4:00 PM EST

Nervgen Pharma (NGEN) Common Equity (2024 - 2026)

Updated

Nervgen Pharma (NGEN) reported Common Equity of $12.16 million for Q2 2026, up 205.6% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Nervgen Pharma posted Common Equity of $4.31 million, down 1.5% from FY2024.

  • By year, Common Equity came in at $4.37 million in FY2024 (+121.8%) and $1.97 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 81.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -4.58 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 51.81 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 13.04 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 89.30 Bn
10 Nervgen Pharma 105.93 Mn 4.82 Mn - 12.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.16 Mn
Mar 31, 2026 3.98 Mn
Dec 31, 2025 4.31 Mn
Dec 31, 2024 4.37 Mn
Jan 1, 2024 1.97 Mn
API Access

Nervgen Pharma Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=NGEN&period=max&api_key=YOUR_API_KEY